Ribomic Statistics
Total Valuation
Ribomic has a market cap or net worth of JPY 5.27 billion. The enterprise value is 2.07 billion.
| Market Cap | 5.27B |
| Enterprise Value | 2.07B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ribomic has 54.31 million shares outstanding. The number of shares has increased by 22.92% in one year.
| Current Share Class | 54.31M |
| Shares Outstanding | 54.31M |
| Shares Change (YoY) | +22.92% |
| Shares Change (QoQ) | +10.79% |
| Owned by Insiders (%) | 3.14% |
| Owned by Institutions (%) | 10.27% |
| Float | 51.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7,023.94 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.98 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.68
| Current Ratio | 20.68 |
| Quick Ratio | 20.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.94% and return on invested capital (ROIC) is -5,756.94%.
| Return on Equity (ROE) | -32.94% |
| Return on Assets (ROA) | -20.06% |
| Return on Invested Capital (ROIC) | -5,756.94% |
| Return on Capital Employed (ROCE) | -32.98% |
| Weighted Average Cost of Capital (WACC) | 5.75% |
| Revenue Per Employee | 30,000 |
| Profits Per Employee | -41.69M |
| Employee Count | 25 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Ribomic has paid 1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.96% in the last 52 weeks. The beta is 0.27, so Ribomic's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -3.96% |
| 50-Day Moving Average | 83.92 |
| 200-Day Moving Average | 92.70 |
| Relative Strength Index (RSI) | 63.77 |
| Average Volume (20 Days) | 3,408,345 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ribomic had revenue of JPY 750,000 and -1.04 billion in losses. Loss per share was -22.12.
| Revenue | 750,000 |
| Gross Profit | 750,000 |
| Operating Income | -1.06B |
| Pretax Income | -1.04B |
| Net Income | -1.04B |
| EBITDA | -1.07B |
| EBIT | -1.06B |
| Loss Per Share | -22.12 |
Balance Sheet
The company has 3.20 billion in cash and n/a in debt, with a net cash position of 3.20 billion or 58.93 per share.
| Cash & Cash Equivalents | 3.20B |
| Total Debt | n/a |
| Net Cash | 3.20B |
| Net Cash Per Share | 58.93 |
| Equity (Book Value) | 3.22B |
| Book Value Per Share | 59.35 |
| Working Capital | 3.17B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -141,716.67% |
| Pretax Margin | -138,766.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ribomic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.92% |
| Shareholder Yield | -22.92% |
| Earnings Yield | -19.78% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ribomic has an Altman Z-Score of 14.78.
| Altman Z-Score | 14.78 |
| Piotroski F-Score | n/a |